Warfarin v antiplatelets or DOACs, No. (%) 6 (13) 3 (6.5) 2 (4.3) 6 (13) 4 (8.7) 13 (28.3) 12 (26.1)
DOACs v control, No. (%) 1 (25) NR NR NR NR 2 (50) 1 (25) 0.08